Patents by Inventor Michael Peter HAHN

Michael Peter HAHN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Isofagomine salts, methods of use and formulations
    Patent number: 12286400
    Abstract: The present invention relates generally to the field of pharmaceuticals, and specifically relates to isofagomine (IFG), novel salts thereof and preparation methods and uses of these, for example, in formulating pharmaceutical compositions for the treatment of Gaucher disease. Also provided are novel crystalline forms of isofagomine salts, methods for preparing the crystalline forms, and their use in formulating pharmaceutical compositions.
    Type: Grant
    Filed: April 24, 2020
    Date of Patent: April 29, 2025
    Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
    Inventors: Helge Reisch, Jeffrey Scott Depue, Fritz Blatter, Jennifer Robin, Michael Peter Hahn, Gaozhong Zhu, Muthuraman Meiyappan
  • ISOFAGOMINE SALTS, METHODS OF USE AND FORMULATIONS
    Publication number: 20230110129
    Abstract: The present invention relates generally to the field of pharmaceuticals, and specifically relates to isofagomine (IFG), novel salts thereof and preparation methods and uses of these, for example, in formulating pharmaceutical compositions for the treatment of Gaucher disease. Also provided are novel crystalline forms of isofagomine salts, methods for preparing the crystalline forms, and their use in formulating pharmaceutical compositions.
    Type: Application
    Filed: April 24, 2020
    Publication date: April 13, 2023
    Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED
    Inventors: Helge REISCH, Jeffrey Scott DEPUE, Fritz BLATTER, Jennifer ROBIN, Michael Peter HAHN, Gaozhong ZHU, Muthuraman MEIYAPPAN